We are live on ! Find out more
MDWD icon

MediWound

23 hedge funds and large institutions have $13.5M invested in MediWound in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

38% more capital invested

Capital invested by funds: $9.76M → $13.5M (+$3.73M)

10% more funds holding

Funds holding: 2123 (+2)

6.16% less ownership

Funds ownership: 22.85%16.69% (-6.2%)

Holders
23
Holders Change
+2
Holders Change %
+9.52%
% of All Funds
0.47%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
7
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change

MDWD Hedge Fund Activity: Q2 2020 in Review

23 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in MediWound (MDWD) for Q2 2020, worth a combined $13.5M — up 38% from $9.76M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new MDWD positions and 2 closed out — a net gain of 2 holders — while 7 added to existing stakes and 3 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $436K. The largest seller was Wellington Management Group, cutting an estimated $4.19M.

  • 23 institutional investors held MediWound (MDWD) as of Q2 2020, up from 21 in Q1 2020.
  • Funds reported $13.5M of MediWound stock for Q2 2020, up 38% quarter-over-quarter.
  • 4 funds opened new MediWound positions in Q2 2020 and 2 closed out, a net change of +2 holders.
  • The largest MediWound buyer in Q2 2020 was Renaissance Technologies, an estimated $436K added.
  • The largest MediWound seller in Q2 2020 was Wellington Management Group, an estimated $4.19M sold.

Based on aggregated 13F filings for Q2 2020.